Commentary: "Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression"

Review Paper A Metaanalysis of Clinical Trials Comparing Moclobemide With Selective Serotonin Reuptake Inhibitors for the Treatment of Major Depressive Disorder

George I Papakostas

February 2015

Objective: To compare response rates among patients with major depressive disorder (MDD) treated wit...

A Review of Serotonin’s Role in Depression and Modern Perspectives

McLaughlin, Liam

May 2022

Major depressive disorder (MDD) is a highly prevalent and debilitating illness in the modern world. ...

Review Article Antidepressants and the Placebo Effect

Irving Kirsch

August 2016

Abstract. Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack ...

Commentary: "Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression"

Fried, E.I.
Boschloo, L.
van Borkulo, C.D.
Schoevers, R.A.
Romeijn, J.-W.
Wichers, M.
de Jonge, P.
Nesse, R.M.
Tuerlinckx, F.
Borsboom, D.

January 2015

In the past decades, almost all research in psychiatry and clinical psychology has been directed at ...

Biomarker Studies And The Future Of Personalized Treatment For Depression: Commentary: Biomarkers And Personalized Treatment

Oquendo, Maria A.
McGrath, Patrick
Weissman, Myrna M.

January 2014

Although the efficacy for numerous antidepressant medications against placebo or no treatment for th...

Commentary: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression

Cumming, Paul
Gryglewski, Gregor
Kranz, Georg
Lanzenberger, Rupert

January 2016

Meta-analyses are one of the cornerstones of evidence-based medicine. This is especially true as per...

Personalized Prediction Of Antidepressant V. Placebo Response: Evidence From The Embarc Study

Webb, Christian A.
Trivedi, Madhukar H.
Cohen, Zachary D.
Dillon, Daniel G.
Fournier, Jay C.
Goer, Franziska
Fava, Maurizio
McGrath, Patrick J.
Weissman, Myrna M.
Parsey, Ramin
Adams, Phil
Trombello, Joseph M.
Cooper, Crystal
Deldin, Patricia
Oquendo, Maria A.
McInnis, Melvin G.
Huys, Quentin
Bruder, Gerard
Kurian, Benji T.
Jha, Manish
DeRubeis, Robert J.
Pizzagalli, Diego A.

January 2019

Background. Major depressive disorder (MDD) is a highly heterogeneous condition in terms of symptom ...

Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.

Hieronymus, F
Emilsson, Johan Fredrik
Nilsson, Staffan
Eriksson, Elias

January 2016

The recent questioning of the antidepressant effect of selective serotonin reuptake inhibitors (SSRI...

On the Effects of Serotonin Reuptake Inhibitors in Major Depression

Hieronymus, Fredrik

January 2019

This thesis focuses on the antidepressant effects of selective serotonin reuptake inhibitors (SSRIs)...

Effect of treatments for depression on quality of life: a meta-analysis

Hofmann, Stefan G.
Curtiss, Joshua
Carpenter, Joseph K.
Kind, Shelley

January 2017

Published in final edited form as: Cogn Behav Ther. 2017 June; 46(4): 265–286. doi:10.1080/16506073....

Guest Editorial / Misafir EditoryalDüşünen Adam The Journal of Psychiatry and Neurological Sciences 2014;27:181-185 DOI: 10.5350/DAJPN20142703001

Ali Saffet Gonul
Burcu Aksoy

November 2015

Major depressive disorder with a prevalence of 8-16 % is one of the most common psychiatric diseases...

Cognitive impairment in depression and its (non-)response to antidepressant treatment

Halahakoon, DC
Roiser, JP

November 2016

ABSTRACT FROM: Shilyansky C, Williams LM, Gyurak A, et al. Effect of antidepressant treatment on cog...

E = MC²

Dorn, MD, John Matt

August 2011

Book Review: WHY PSYCHOTHERAPISTS FAILRichard D. Chessick, M.D.New York: Jason Aronson, 1971203 pp.,...

OPEN ORIGINAL ARTICLE

The International
Ssri Pharmacogenomics Consortium
R Weinshilboum

August 2016

Response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably betwe...

Reviewed by:

Adam M. Chekroud
Philip R. Corlett
Christoph Daniel Mathys
Adam M. Chekroud

January 2015

Major Depressive Disorder is a debilitating and increasingly prevalent psychiatric condition (Compto...

Review Paper A Metaanalysis of Clinical Trials Comparing Moclobemide With Selective Serotonin Reuptake Inhibitors for the Treatment of Major Depressive Disorder

George I Papakostas

February 2015

Objective: To compare response rates among patients with major depressive disorder (MDD) treated wit...

A Review of Serotonin’s Role in Depression and Modern Perspectives

McLaughlin, Liam

May 2022

Major depressive disorder (MDD) is a highly prevalent and debilitating illness in the modern world. ...

Review Article Antidepressants and the Placebo Effect

Irving Kirsch

August 2016

Abstract. Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack ...

Commentary: "Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression"

Fried, E.I.
Boschloo, L.
van Borkulo, C.D.
Schoevers, R.A.
Romeijn, J.-W.
Wichers, M.
de Jonge, P.
Nesse, R.M.
Tuerlinckx, F.
Borsboom, D.

January 2015

In the past decades, almost all research in psychiatry and clinical psychology has been directed at ...

Biomarker Studies And The Future Of Personalized Treatment For Depression: Commentary: Biomarkers And Personalized Treatment

Oquendo, Maria A.
McGrath, Patrick
Weissman, Myrna M.

January 2014

Although the efficacy for numerous antidepressant medications against placebo or no treatment for th...

Commentary: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression

Cumming, Paul
Gryglewski, Gregor
Kranz, Georg
Lanzenberger, Rupert

January 2016

Meta-analyses are one of the cornerstones of evidence-based medicine. This is especially true as per...

Personalized Prediction Of Antidepressant V. Placebo Response: Evidence From The Embarc Study

Webb, Christian A.
Trivedi, Madhukar H.
Cohen, Zachary D.
Dillon, Daniel G.
Fournier, Jay C.
Goer, Franziska
Fava, Maurizio
McGrath, Patrick J.
Weissman, Myrna M.
Parsey, Ramin
Adams, Phil
Trombello, Joseph M.
Cooper, Crystal
Deldin, Patricia
Oquendo, Maria A.
McInnis, Melvin G.
Huys, Quentin
Bruder, Gerard
Kurian, Benji T.
Jha, Manish
DeRubeis, Robert J.
Pizzagalli, Diego A.

January 2019

Background. Major depressive disorder (MDD) is a highly heterogeneous condition in terms of symptom ...

Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.

Hieronymus, F
Emilsson, Johan Fredrik
Nilsson, Staffan
Eriksson, Elias

January 2016

The recent questioning of the antidepressant effect of selective serotonin reuptake inhibitors (SSRI...

On the Effects of Serotonin Reuptake Inhibitors in Major Depression

Hieronymus, Fredrik

January 2019

This thesis focuses on the antidepressant effects of selective serotonin reuptake inhibitors (SSRIs)...

Effect of treatments for depression on quality of life: a meta-analysis

Hofmann, Stefan G.
Curtiss, Joshua
Carpenter, Joseph K.
Kind, Shelley

January 2017

Published in final edited form as: Cogn Behav Ther. 2017 June; 46(4): 265–286. doi:10.1080/16506073....

Guest Editorial / Misafir EditoryalDüşünen Adam The Journal of Psychiatry and Neurological Sciences 2014;27:181-185 DOI: 10.5350/DAJPN20142703001

Ali Saffet Gonul
Burcu Aksoy

November 2015

Major depressive disorder with a prevalence of 8-16 % is one of the most common psychiatric diseases...

Cognitive impairment in depression and its (non-)response to antidepressant treatment

Halahakoon, DC
Roiser, JP

November 2016

ABSTRACT FROM: Shilyansky C, Williams LM, Gyurak A, et al. Effect of antidepressant treatment on cog...

E = MC²

Dorn, MD, John Matt

August 2011

Book Review: WHY PSYCHOTHERAPISTS FAILRichard D. Chessick, M.D.New York: Jason Aronson, 1971203 pp.,...

OPEN ORIGINAL ARTICLE

The International
Ssri Pharmacogenomics Consortium
R Weinshilboum

August 2016

Response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably betwe...

Reviewed by:

Adam M. Chekroud
Philip R. Corlett
Christoph Daniel Mathys
Adam M. Chekroud

January 2015

Major Depressive Disorder is a debilitating and increasingly prevalent psychiatric condition (Compto...

Review Paper A Metaanalysis of Clinical Trials Comparing Moclobemide With Selective Serotonin Reuptake Inhibitors for the Treatment of Major Depressive Disorder

George I Papakostas

February 2015

Objective: To compare response rates among patients with major depressive disorder (MDD) treated wit...

A Review of Serotonin’s Role in Depression and Modern Perspectives

McLaughlin, Liam

May 2022

Major depressive disorder (MDD) is a highly prevalent and debilitating illness in the modern world. ...

Review Article Antidepressants and the Placebo Effect

Irving Kirsch

August 2016

Abstract. Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack ...

Commentary: "Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression"

Abstract

Extracted data

Commentary: "Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression"

Abstract

Extracted data

Related items

Related items